Gene: LRRC20
Official Full Name: leucine rich repeat containing 20provided by HGNC
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO16466 | LRRC20 Knockout cell line (HeLa) | Human | LRRC20 | 1:3~1:6 | Negative | Online Inquiry |
KO16467 | LRRC20 Knockout cell line (HCT 116) | Human | LRRC20 | 1:2~1:4 | Negative | Online Inquiry |
KO16468 | LRRC20 Knockout cell line (HEK293) | Human | LRRC20 | 1:3~1:6 | Negative | Online Inquiry |
KO16469 | LRRC20 Knockout cell line (A549) | Human | LRRC20 | 1:3~1:4 | Negative | Online Inquiry |
LRRC20 Gene Knockout Cell Lines are genetically modified cell lines in which the LRRC20 gene has been specifically disrupted, providing a powerful tool for researchers aiming to investigate the gene's functional role in various biological processes and diseases. This precise manipulation is achieved through advanced genome-editing technologies such as CRISPR/Cas9, allowing for high specificity in targeting the gene of interest. By knocking out LRRC20, researchers can study the phenotypic consequences of its absence, elucidating its contribution to cellular mechanisms and signaling pathways.
The primary function of LRRC20 Gene Knockout Cell Lines lies in their utility for functional genomics studies. By comparing wild-type and knockout cells, scientists can discern how the loss of LRRC20 impacts cellular behaviors such as differentiation, proliferation, and response to stimuli. This is particularly significant in cancer research, where the LRRC20 gene has been implicated in tumorigenesis and metastasis. The data gleaned from these studies can pave the way for novel diagnostic or therapeutic strategies targeting LRRC20-related pathways.
One of the distinct advantages of our LRRC20 Gene Knockout Cell Lines is the robustness of our development process, which ensures high knockout efficiency and minimal off-target effects. This precision enables researchers to confidently interpret their results, reducing the complexities often associated with less refined genetic modifications. Furthermore, these cell lines are readily available for collaboration, accelerating the pace of research and discovery.
For researchers and clinicians, the LRRC20 Gene Knockout Cell Lines represent a strategic asset that enhances experimental design and expands the repertoire of tools available for tackling challenging research questions. The ability to manipulate and study specific gene functions in a controlled environment is invaluable for driving innovation within molecular biology, genetics, and therapeutic development.
Our company prides itself on its commitment to delivering high-quality biological products backed by rigorous scientific validation. With a team of expert scientists dedicated to advancing research capabilities through genetic engineering, we provide products that not only meet but exceed the expectations of the scientific community.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.